Human-Relevant Predictive Platforms. Multiparametric, Real-Time Insights
Integrated microfluidic and organ-on-chip technologies designed to generate predictive, high-content functional data for neurological and neuromuscular research.
NeuroHTS™
Precisely organized neuronal cultures enabling reproducible network formation for scalable, multiparametric screening across diverse experimental conditions.
Read More
NeuroMuscle™
Human neuromuscular junction-on-a-chip platform enabling disease modeling, neurotoxicity assessment, and scalable preclinical drug screening.
Read More
A Paradigm Shift in Organ-on-Chip (OoC) and Microphysiological Systems (MPS) Technologies
At Ananda Devices, we are dedicated to the development of novel MPS/OoC systems that will help propel more relevant human research and discovery efforts. OoC technologies are critical because they provide a more physiological context for cells that more closely resemble their organization, function, structure and behavior in the human body.
Building Better Human-Centric Neuro Models
With the announcement of the FDA Modernization Act and similar efforts worldwide to reduce animal testing, there is a growing need to advance novel assay methodologies and non-animal testing paradigms (NAMS), of which OoC's are a key core technology.
Neurological diseases research is a key area where traditional animal models and assay technologies have fallen short. Many human neurological conditions are simply not represented well or even relevant in animals and Ananda Devices has made it our primary mission to develop and build better model systems that will allow broad adoption of accessible technologies and tools to address this need.
Why the Industry is Shifting to MPS & OoC
In addition to the growing need for better models, the industry is increasingly turning to MPS and OoC technologies for several key reasons. These platforms offer more human-relevant insights, improve predictive accuracy, and support the shift toward more efficient and ethical drug development.
1
Improved predictivity
Provide a better model for improved understanding of the efficacy,potency and activity of test articles in advanced human cell systems.
2
Reduced animal testing
Drug failure rates continue to drive increased costs and late-stageprogram failures. The lack of relevant human models is likely a key contributor to theseoverall metrics for the industry.
3
Biological relevance
The controlled and more complex cellular environment in MPS and OoC devices allows researchers to assess test molecule behavior in systems that more closely resemble in vivo biology. Most models are not perfect, but these better mimic multi-cell environments where cells are precisely organized as in human tissues.
4
Personalized medicine
Combined with technologies such as human induced pluripotent stem cells (iPSCs), these systems enable patient-derived cells for more personalized and predictive testing. They also support early-stage clinical modeling through diverse cell banks representing broad human populations.
Improving Outcomes in Neurological Health
At Ananda Devices, we believe that the efficiency of the drug discovery process and efforts to improve the lives of patients with neurological conditions can be significantly advanced through human-relevant cellular systems built on MPS and OoC platforms. We are proud to offer two such approaches through our NeuroHTS™ and NeuroMuscle™ products and services, and invite you to learn more in the Products section of our website.
Accelerate Your Research with NAMs!
Explore Technologies
Request a Proposal
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
Terms and Conditions
Languages: EN
Human-Relevant Predictive Platforms. Multiparametric, Real-Time Insights
Integrated microfluidic and organ-on-chip technologies designed to generate predictive, high-content functional data for neurological and neuromuscular research.
Precisely organized neuronal cultures enabling reproducible network formation for scalable, multiparametric screening across diverse experimental conditions.
Read More
NeuroHTS™
NeuroMuscle™
A Paradigm Shift in Organ-on-Chip (OoC) and Microphysiological Systems (MPS) Technologies
At Ananda Devices, we are dedicated to the development of novel MPS/OoC systems that will help propel more relevant human research and discovery efforts. OoC technologies are critical because they provide a more physiological context for cells that more closely resemble their organization, function, structure and behavior in the human body.
Building Better Human-Centric Neuro Models
With the announcement of the FDA Modernization Act and similar efforts worldwide to reduce animal testing, there is a growing need to advance novel assay methodologies and non-animal testing paradigms (NAMS), of which OoC's are a key core technology.
Neurological diseases research is a key area where traditional animal models and assay technologies have fallen short. Many human neurological conditions are simply not represented well or even relevant in animals and Ananda Devices has made it our primary mission to develop and build better model systems that will allow broad adoption of accessible technologies and tools to address this need.
Why the Industry is Shifting to MPS & OoC
In addition to the growing need for better models, the industry is increasingly turning to MPS and OoC technologies for several key reasons. These platforms offer more human-relevant insights, improve predictive accuracy, and support the shift toward more efficient and ethical drug development.
1
Improved predictivity
Provide a better model for improved understanding of the efficacy,potency and activity of test articles in advanced human cell systems.
Improving Outcomes in Neurological Health
At Ananda Devices, we believe that the efficiency of the drug discovery process and efforts to improve the lives of patients with neurological conditions can be significantly advanced through human-relevant cellular systems built on MPS and OoC platforms. We are proud to offer two such approaches through our NeuroHTS™ and NeuroMuscle™ products and services, and invite you to learn more in the Products section of our website.
Accelerate Your Research with NAMs!
Explore Technologies
Request a Proposal
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN
Human-Relevant Predictive Platforms. Multiparametric, Real-Time Insights
Integrated microfluidic and organ-on-chip technologies designed to generate predictive, high-content functional data for neurological and neuromuscular research.
Precisely organized neuronal cultures enabling reproducible network formation for scalable, multiparametric screening across diverse experimental conditions.
Read More
NeuroHTS™
NeuroMuscle™
A Paradigm Shift in Organ-on-Chip (OoC) and Microphysiological Systems (MPS) Technologies
At Ananda Devices, we are dedicated to the development of novel MPS/OoC systems that will help propel more relevant human research and discovery efforts. OoC technologies are critical because they provide a more physiological context for cells that more closely resemble their organization, function, structure and behavior in the human body.
Building Better Human-Centric Neuro Models
With the announcement of the FDA Modernization Act and similar efforts worldwide to reduce animal testing, there is a growing need to advance novel assay methodologies and non-animal testing paradigms (NAMS), of which OoC's are a key core technology.
Neurological diseases research is a key area where traditional animal models and assay technologies have fallen short. Many human neurological conditions are simply not represented well or even relevant in animals and Ananda Devices has made it our primary mission to develop and build better model systems that will allow broad adoption of accessible technologies and tools to address this need.
Why the Industry is Shifting to MPS & OoC
In addition to the growing need for better models, the industry is increasingly turning to MPS and OoC technologies for several key reasons. These platforms offer more human-relevant insights, improve predictive accuracy, and support the shift toward more efficient and ethical drug development.
1
Improved predictivity
Provide a better model for improved understanding of the efficacy,potency and activity of test articles in advanced human cell systems.
2
Reduced animal testing
Drug failure rates continue to drive increased costs and late-stageprogram failures. The lack of relevant human models is likely a key contributor to theseoverall metrics for the industry.
3
Biological relevance
The controlled and more complex cellular environment in MPS and OoC devices allows researchers to assess test molecule behavior in systems that more closely resemble in vivo biology. Most models are not perfect, but these better mimic multi-cell environments where cells are precisely organized as in human tissues.
4
Personalized medicine
Combined with technologies such as human induced pluripotent stem cells (iPSCs), these systems enable patient-derived cells for more personalized and predictive testing. They also support early-stage clinical modeling through diverse cell banks representing broad human populations.
Improving Outcomes in Neurological Health
At Ananda Devices, we believe that the efficiency of the drug discovery process and efforts to improve the lives of patients with neurological conditions can be significantly advanced through human-relevant cellular systems built on MPS and OoC platforms. We are proud to offer two such approaches through our NeuroHTS™ and NeuroMuscle™ products and services, and invite you to learn more in the Products section of our website.
Accelerate Your Research with NAMs!
Explore Technologies
Request a Proposal
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN
Home
About Us
Our Platforms
Our Services
Our Resources
Contact Us
Client Portal
EN